Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Observational Study of Site-Specific Incident and Prevalent Cases of Cancer in People Living With HIV/AIDS- in Latin America

NCT04089488 is registered in ClinicalTrials.gov with AIDS Malignancy Consortium as lead sponsor.

NCT NCT04089488
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04089488 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Observational Study of Site-Specific Incident and Prevalent Cases of Cancer in People Living With HIV/AIDS- in Latin America
Lead sponsor
AIDS Malignancy Consortium
Phase
Observational
Overall status
Completed
Start date
January 17, 2020
Completion date
October 18, 2021
Enrollment
175 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infection, human immunodeficiency virus 1 positive, malignant neoplasm, recurrent malignant neoplasm